Evidence map›Paper›PMID 35608020›Full record

ArticleDevelopment (Cambridge, England)2022

Chondroitin sulfate enhances the barrier function of basement membrane assembled by heparan sulfate.

Chenqi Tao, Neoklis Makrides, Jen-Zen Chuang, Yihua Wu, Steven E Brooks, Jeffrey D Esko, Ching-Hwa Sung, Xin Zhang

Open access · hybridAbstract read
In one paragraph

Article in Development (Cambridge, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact, top 99% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 0 citations in OpenAlex.

  1. Article
  2. Article
  3. Endothelial glycocalyx in retina, hyperglycemia, and diabetic retinopathy.American journal of physiology. Cell physiology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Chenqi TaoDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.ORCID 0000-0002-4346-7343
Neoklis MakridesDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.
Jen-Zen ChuangDepartment of Ophthalmology, Dyson Vision Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Yihua WuDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.
Steven E BrooksDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.
Jeffrey D EskoDepartment of Cellular and Molecular Medicine, Glycobiology Research and Training Center, University of California San Diego, La Jolla, CA 92093, USA.ORCID 0000-0001-8322-1834
Ching-Hwa SungDepartment of Ophthalmology, Dyson Vision Research Institute, Weill Cornell Medicine, New York, NY 10065, USA.
Xin ZhangDepartment of Ophthalmology, Columbia University, New York, NY 10032, USA.ORCID 0000-0001-5555-0825

Funding

Siglec Modulation of Inflammation in Humans and MiceP01HL057345 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI VARKI, NISSI MARY · 1997 to 2012
$24.1M
Siglec Modulation of Inflammatory ResponsesP01HL107150 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI LE, DZUNG T · 2011 to 2017
$18.0M
Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Signaling Mechanisms of Lens DevelopmentR01EY017061 · NEI · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI ZHANG, XIN · 2006 to 2025
$9.0M
Regulation of FGF signaling in lacrimal gland developmentR01EY018868 · NEI · INDIANA UNIVERSITY INDIANAPOLIS · PI Xin Zhang · 2009 to 2026
$6.3M
Endosome regulated retinal homeostasis and diseaseR01EY029428 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI CHING-HWA SUNG · 2018 to 2026
$3.8M
Structural and functional integrity and microenvironment of RPE cellsR01EY016805 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SUNG, CHING-HWA · 2006 to 2015
$3.5M
PDGF signaling in lens developmentR01EY025933 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, XIN · 2015 to 2023
$3.2M
Modeling and mechanistic investigation of a novel dry AMD mouse model with CLIC4 deleted in RPER01EY032966 · NEI · WEILL MEDICAL COLL OF CORNELL UNIV · PI SUNG, CHING-HWA · 2021 to 2024
$1.7M
Mechanism of Csk signaling in lacrimal gland morphogenesisR01EY031210 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI ZHANG, XIN · 2020 to 2023
$1.6M
NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY016805NEI NIH HHS R01 EY017061NEI NIH HHS R01 EY018868NEI NIH HHS R01 EY025933NEI NIH HHS R01 EY029428NEI NIH HHS R01 EY031210NEI NIH HHS R01 EY032966NHLBI NIH HHS P01 HL057345NHLBI NIH HHS P01 HL107150
6 · The paper itself

Abstract

Glycosaminoglycans are ubiquitously expressed polysaccharides that are attached to proteoglycans. Here, we showed that ablation of the heparan sulfate (HS) polymerase Ext1 in retinal progenitor cells did not affect initial progression of retinal angiogenesis, but it disrupted the pruning of blood vessels and establishment of arterioles and venules. In the absence of retinal HS, blood vessels were also vulnerable to high oxygen tension in early postnatal stages, which could be rescued by exogenous vascular endothelial growth factor (VEGF), consistent with the role of retinal HS in the fine-tuning of VEGF signaling. Furthermore, we observed that the retinal inner limiting membrane (ILM) was disrupted by deletion of Ext1 in a timing-specific manner, suggesting that retinal HS is required for the assembly but not the maintenance of the basement membrane. Lastly, we showed that further deletion of C4st1, a chondroitin sulfate (CS) sulfation enzyme, did not affect the assembly of the ILM but, when combined with Ext1 deletion, it aggravated the retinal permeability by disrupting the retinal glycocalyx. These results demonstrate an important role of CS and HS in establishing the barrier function of the extracellular matrix.

Indexed as

Chondroitin SulfatesVascular Endothelial Growth Factor ABasement MembraneGlycosaminoglycansHeparan SulfateHeparan Sulfate ProteoglycansChondroitin SulfatesGlycosaminoglycansHeparan SulfateHeparan Sulfate ProteoglycansVascular Endothelial Growth Factor AAngiogenesisAstrocyteBasement membraneChondroitin sulfateGlycocalyxRetina

Identifiers

PMID35608020
PMCPMC9270973
OpenAlexW35608020

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.